These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 25128040)
21. Developing a valid patient-reported outcome measure. Rothrock NE; Kaiser KA; Cella D Clin Pharmacol Ther; 2011 Nov; 90(5):737-42. PubMed ID: 21975345 [TBL] [Abstract][Full Text] [Related]
22. Myth of evidence-based medicine for bipolar disorder. Post RM Expert Rev Neurother; 2009 Sep; 9(9):1271-3. PubMed ID: 19769442 [No Abstract] [Full Text] [Related]
23. Comments on the ISPOR Task Force Report on Translation and Adaptation of Outcomes Measures: guidelines and the need for more research. Lenderking WR Value Health; 2005; 8(2):92-3. PubMed ID: 15804317 [No Abstract] [Full Text] [Related]
24. Using factor analysis to confirm the validity of children's self-reported health-related quality of life across different modes of administration. Varni JW; Limbers CA; Newman DA Clin Trials; 2009 Apr; 6(2):185-95. PubMed ID: 19342471 [TBL] [Abstract][Full Text] [Related]
25. Optimising outcome assessment to improve quality and efficiency of stroke trials. McArthur K; Fan Y; Pei Z; Quinn T Expert Rev Pharmacoecon Outcomes Res; 2014 Feb; 14(1):101-11. PubMed ID: 24350886 [TBL] [Abstract][Full Text] [Related]
26. Pain palliation measurement in cancer clinical trials: the US Food and Drug Administration perspective. Basch E; Trentacosti AM; Burke LB; Kwitkowski V; Kane RC; Autio KA; Papadopoulos E; Stansbury JP; Kluetz PG; Smith H; Justice R; Pazdur R Cancer; 2014 Mar; 120(5):761-7. PubMed ID: 24375398 [TBL] [Abstract][Full Text] [Related]
27. Are surrogate endpoints useful in clinical studies? Amdal CD; Bjordal K Tidsskr Nor Laegeforen; 2014 Jun; 134(11):1128-9. PubMed ID: 24939776 [No Abstract] [Full Text] [Related]
28. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus. Gordon C; Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostál C; Font J; Gilboe IM; Houssiau F; Huizinga TW; Isenberg D; Kallenberg CG; Khamashta MA; Piette JC; Schneider M; Smolen JS; Sturfelt G; Tincani A; Van Vollenhoven R; Boumpas DT Ann Rheum Dis; 2009 Apr; 68(4):470-6. PubMed ID: 18388158 [TBL] [Abstract][Full Text] [Related]
29. Positive clinical trials: understand the control group before implementing the result. Parshuram CS; Kavanagh BP Am J Respir Crit Care Med; 2004 Aug; 170(3):223-6. PubMed ID: 15151921 [No Abstract] [Full Text] [Related]
30. Looking back or looking forward? Sommer A; Steinmann WC Ophthalmic Surg; 1989 Jan; 20(1):70-1. PubMed ID: 2927884 [No Abstract] [Full Text] [Related]
31. A review of the limitations of statistical analysis of treatment outcomes used in periodontal research. Galgut PN J Int Acad Periodontol; 2003 Oct; 5(4):92-7. PubMed ID: 14604057 [TBL] [Abstract][Full Text] [Related]
32. Digitization of patient-reported outcomes. Forrest CB Value Health; 2013 Jun; 16(4):459-60. PubMed ID: 23796279 [No Abstract] [Full Text] [Related]
33. Economic analysis alongside clinical trials. Revisiting the methodological issues. Drummond MF; Davies L Int J Technol Assess Health Care; 1991; 7(4):561-73. PubMed ID: 1778701 [TBL] [Abstract][Full Text] [Related]
35. Ethnopharmacology, sustainable development and cooperation: the importance of gathering clinical data during field surveys. Graz B; Falquet J; Elisabetsky E J Ethnopharmacol; 2010 Aug; 130(3):635-8. PubMed ID: 20466053 [No Abstract] [Full Text] [Related]
36. Measurement implications when developing and implementing interventions. Strickland OL J Nurs Meas; 2005; 13(3):171-3. PubMed ID: 16605040 [No Abstract] [Full Text] [Related]
37. Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and reporting team. Crowe BJ; Xia HA; Berlin JA; Watson DJ; Shi H; Lin SL; Kuebler J; Schriver RC; Santanello NC; Rochester G; Porter JB; Oster M; Mehrotra DV; Li Z; King EC; Harpur ES; Hall DB Clin Trials; 2009 Oct; 6(5):430-40. PubMed ID: 19846894 [TBL] [Abstract][Full Text] [Related]
39. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part I. Berger ML; Mamdani M; Atkins D; Johnson ML Value Health; 2009; 12(8):1044-52. PubMed ID: 19793072 [TBL] [Abstract][Full Text] [Related]
40. Quality assurance of data: ensuring that numbers reflect operational definitions and contain real measurements. Rieder HL; Lauritsen JM Int J Tuberc Lung Dis; 2011 Mar; 15(3):296-304. PubMed ID: 21333095 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]